Paul Kim

Paul H.
Kim is currently Chief Executive Officer at Matica Biotechnology, Inc. since 2024.
Mr. Kim serves as Independent Director at Exagen, Inc. since 2023.
Mr. Kim holds the position of Chief Financial Officer at Fulgent Therapeutics LLC and Fulgent Genetics, Inc., both since 2016.
Former roles include Director at WCCT Global, Inc. and PharmAbcine Inc., Principal at Heron Therapeutics, Inc., CG Invites Co., Ltd., and Viro-Med Laboratories, Inc. Mr. Kim was Controller at Interlink Computer Sciences, Inc. from 1996 to 1998, Vice President-Finance & Administration at Datafusion, Inc. from 1998 to 1999, Chief Financial Officer at AMCC Enterprise Corp.
from 2002 to 2003, and Chief Financial Officer at Gemalto Cogent, Inc. and Cogent, Inc. from 2004 to 2011.
Mr. Kim worked as Audit Manager at Coopers & Lybrand LLP from 1990 to 1996.
Education includes an undergraduate degree from the University of California, Berkeley in 1989 and an MBA from the Tuck School of Business at Dartmouth.